Clinical Features of Fluid Retention Complicating Treatment with Guanethidine
- 1 April 1965
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 31 (4), 485-489
- https://doi.org/10.1161/01.cir.31.4.485
Abstract
Forty-four (32.8 per cent) of 134 patients [see figure in the PDF file] treated continuously with guanethidine for a period of at least 12 months developed recognizable fluid retention. Previous edema may be a predisposing factor and fluid retention occurred more commonly in women. Neither of these factors offers a complete explanation of this side effect. No evidence has been found to suggest that fluid retention occurs preferentially in patients with renal or cardiac insufficiency. The findings are compatible with a universal fluidretaining influence of guanethidine presenting as a graded phenomenon.Keywords
This publication has 11 references indexed in Scilit:
- METHYLDOPA IN HYPERTENSION CLINICAL AND PHARMACOLOGICAL STUDIESThe Lancet, 1962
- FURTHER EXPERIENCE WITH GUANETHIDINEThe Lancet, 1961
- Variations in Blood‐volume during Treatment of Hypertension with Ganglion‐blocking Agents and Thiazide‐preparationsActa Medica Scandinavica, 1961
- CLINICAL AND PHARMACOLOGICAL STUDIES WITH GUANETHIDINE IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1960
- GUANETHIDINE: HYPOTENSIVE DRUG WITH PROLONGED ACTIONThe Lancet, 1959
- The Complications of Reserpine TherapyPostgraduate Medical Journal, 1957
- Reserpine and Extracellular-Fluid VolumeNew England Journal of Medicine, 1957
- HEART-FAILURE FROM RETENTION OF SALT AND WATER CAUSED BY TREATMENT WITH PENTAPYRROLIDINIUM BITARTRATEThe Lancet, 1955
- FLUID RETENTION DURING METHONIUM THERAPYInternal Medicine Journal, 1954
- Rauwolfia serpentina in Hypertensive Vascular Disease.,Experimental Biology and Medicine, 1954